Download PDF
Krankenhaushygiene up2date 2013; 08(02): 101-113
DOI: 10.1055/s-0033-1344235
Nosokomiale Infektionen
© Georg Thieme Verlag KG Stuttgart · New York

Gibt es Geschlechterunterschiede bei Infektionen?

Magda Diab-Elschahawi
,
Elisabeth Presterl
Further Information

Publication History

Publication Date:
04 July 2013 (online)

Also available at
    Permissions and Reprints All articles of this category

Kernaussagen

Nicht nur die anatomischen Unterschiede von Frauen und Männern tragen zu den unterschiedlichen Manifestationen und Häufigkeiten von Infektionskrankheiten bei beiden Geschlechtern bei, sondern auch weitere wichtige Faktoren wie Hormone, Immunsystem und ihre Gender-Rolle in der Gesellschaft. Diese Unterschiede sind im Hinblick auf Präventivmaßnahmen zunehmend zu berücksichtigen.

 

  • Literatur

  • 1 Schroder J, Kahlke V, Staubach KH et al. Gender differences in human sepsis. Arch Surg 1998; 133: 1200-1205
    CrossrefGoogle Scholar
  • 2 Offner PJ, Moore EE, Biffl WL. Male gender is a risk factor for major infections after surgery. Arch Surg 1999; 134: 935-938 ; discussion 8-40
    CrossrefGoogle Scholar
  • 3 Wichmann MW, Inthorn D, Andress HJ et al. Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med 2000; 26: 167-172
    CrossrefGoogle Scholar
  • 4 Eachempati SR, Hydo L, Barie PS. Gender-based differences in outcome in patients with sepsis. Arch Surg 1999; 134: 1342-1347
    CrossrefGoogle Scholar
  • 5 Libert C, Dejager L, Pinheiro I. The X chromosome in immune functions: when a chromosome makes the difference. Nat Rev Immunol 2010; 10: 594-604
    CrossrefPubMedGoogle Scholar
  • 6 Mnyani CN, McIntyre JA. Tuberculosis in pregnancy. Br J Obstet Gynecol 2011; 118: 226-231
    CrossrefGoogle Scholar
  • 7 Gonzalez DA, Diaz BB, Rodriguez Perez Mdel C et al. Sex hormones and autoimmunity. Immunol Lett 2010; 133: 6-13
    CrossrefGoogle Scholar
  • 8 Gleicher N, Barad DH. Gender as risk factor for autoimmune diseases. J Autoimmun 2007; 28: 1-6
    CrossrefGoogle Scholar
  • 9 Gupta K, Hooton TM, Naber KG et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011; 52: e103-e120
    CrossrefGoogle Scholar
  • 10 Wagenlehner FM, Schmiemann G, Hoyme U et al. [National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients]. Urologe A 2011; 50: 153-169
    CrossrefGoogle Scholar
  • 11 Pietropaoli AP, Glance LG, Oakes D et al. Gender differences in mortality in patients with severe sepsis or septic shock. Gend Med 2010; 7: 422-437
    CrossrefGoogle Scholar
  • 12 Nachtigall I, Tafelski S, Rothbart A et al. Gender-related outcome difference is related to course of sepsis on mixed ICUs: a prospective, observational clinical study. Crit Care 2011; 15: R151
    CrossrefGoogle Scholar
  • 13 WHO ed Global prevalence and incidence of selected curable sexually transmitted infections, overview and estimates. WHO; 2001
    Google Scholar
  • 14 Pedlow CT, Carey MP. Developmentally appropriate sexual risk reduction interventions for adolescents: rationale, review of interventions, and recommendations for research and practice. Ann Behav Med 2004; 27: 172-184
    CrossrefGoogle Scholar
  • 15 European Commission. European Survey on Sexually Transmitted Infections: Sexually transmitted infections – Surveillance in Europe. 2008
    Google Scholar
  • 16 European Centers of Disease Control. Technical Report Mapping of HIV/STI behavioural surveillance. 2009
    Google Scholar
  • 17 Laspina F, Samudio M, Cibils D et al. Epidemiological characteristics of microbiological results on patients with infectious corneal ulcers: a 13-year survey in Paraguay. Graefes Arch Clin Exp Ophthalmol 2004; 242: 204-209
    CrossrefGoogle Scholar
  • 18 Cedrone C, Ricci F, Regine F et al. Nationwide incidence of endophthalmitis among the general population and the subjects at risk of endophthalmitis in Italy. Ophthalmic Epidemiol 2008; 15: 366-371
    CrossrefGoogle Scholar
  • 19 Essex RW, Yi Q, Charles PG et al. Post-traumatic endophthalmitis. Ophthalmology 2004; 111: 2015-2022
    CrossrefGoogle Scholar
  • 20 Erikson K. Smittkoppornas konsekvenser. En studie över smittade födda 1780–1785 i Skelefftea landsförsamling. Unpublished paper. Department of History, Umea University; 1994 – Dank an Frau Prof. Dr. Birgitta Evengard, Dept. Infectious Diseases, Umea University
    Google Scholar
  • 21 Robert-Koch-Institut. Infektionsbiologisches Jahrbuch für 2010. Berlin: 2011
    Google Scholar
  • 22 Klein SL, Jedlicka A, Pekosz A. The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis 2010; 10: 338-349
    CrossrefGoogle Scholar
  • 23 Gaucher D, Therrien R, Kettaf N et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med 2008; 205: 3119-3131
    CrossrefGoogle Scholar
  • 24 Engler RJ, Nelson MR, Klote MM et al. Half- vs full-dose trivalent inactivated influenza vaccine (2004–2005): age, dose, and sex effects on immune responses. Arch Intern Med 2008; 168: 2405-2414
    CrossrefGoogle Scholar
  • 25 Mossong J, O'Callaghan CJ, Ratnam S. Modelling antibody response to measles vaccine and subsequent waning of immunity in a low exposure population. Vaccine 2000; 19: 523-529
    CrossrefGoogle Scholar
  • 26 Davidkin I, Valle M, Julkunen I. Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine-year follow-up. Vaccine 1995; 13: 1617-1622
    CrossrefGoogle Scholar
  • 27 France EK, Glanz J, Xu S et al. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics 2008; 121: e687-e692
    CrossrefGoogle Scholar
  • 28 Hilber AM, Bosch-Capblanch X, Schindler C et al. Gender and immunisation. Summary report for SAGE, November 2010. Zürich: Swiss Centre for International Health STaPHI; 2010
    Google Scholar
  • 29 Soneji S, Metlay J. Mortality reductions for older adults differ by race/ethnicity and gender since the introduction of adult and pediatric pneumococcal vaccines. Public Health Rep 2011; 126: 259-269
    Google Scholar
  • 30 Marek E, Dergez T, Rebek-Nagy G et al. Adolescents’ awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary. Vaccine 2011; 29: 8591-8598
    CrossrefGoogle Scholar
  • 31 Allen JD, de Jesus M, Mars D et al. Decision-making about the HPV vaccine among ethnically diverse parents: implications for health communications. J Oncol 2012; 401979
    Google Scholar
  • 32 Mamelund SE, Riise Bergsaker MA. Vaccine history, gender and influenza vaccination in a household context. Vaccine 2011; 29: 9441-9450
    CrossrefGoogle Scholar